Ignite Creation Date:
2025-12-25 @ 4:08 AM
Ignite Modification Date:
2026-04-08 @ 7:58 AM
Study NCT ID:
NCT00234520
Status:
COMPLETED
Last Update Posted:
2019-08-02
First Post:
2005-10-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Risk of Developing a Heart Condition Called Valvular Regurgitation in Patients With Acromegaly Treated With Either Lanreotide or Octreotide
Sponsor:
Ipsen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-05
Start Date Type:
None
Primary Completion Date:
2005-02-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-02-18
Completion Date Type:
ACTUAL
First Submit Date:
2005-10-05
First Submit QC Date:
None
Study First Post Date:
2005-10-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-08-01
Last Update Post Date:
2019-08-02
Last Update Post Date Type:
ACTUAL